Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Pleural Effusion, Malignant 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neoplasm Metastasis 1Melanoma 1Limited Stage Small Cell Lung Cancer 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Cachexia 1Brain Neoplasms 1

Interventions

Megestrol Acetate 2remune 1ostarine 1nabilone 1clazakizumab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Omacor 1Melatonin 1Infliximab 1Ibuprofen 1Exercise 1Enteral Nutrition 1Docetaxel 1Deuterium Oxide 1Deuterium 1Clarithromycin 1Caseins 1Carnitine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × Sodium Chloride × Thoracic × Clear all
NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CSL Behring

Phase 2 Completed
124 enrolled
Thoracic

Cachexia, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡